Weekly Newsletter   Challenge account


Author Archive

Charter Eyeing MVNO Launch After Time Warner Buyout Closes

Charter Communications (NASDAQ: CHTR) this week officially closed its deal in acquiring Time Warner Cable and Bright House. The natural thought is on how this deal will affect the cable industry. However, there is another benefit that Charter considered in buying Time Warner and it is called an MVNO, and it could be just as Continue reading →

Protect Your Nest Eggs With a Bond Ladder

On Wednesday, Federal Reserve Chair Janet Yellen said that interest rates could be raised next month depending on a wide range of factors that can show whether or not the nation’s economy is improving. In the meantime, investors continue to look for the best ways to spend their money, especially people who are tucking away Continue reading →

Posted by TwillyD May 18, 2016

What’s Old is New Again; Nokia Hopes So

Remember when the hottest cellphones in the market were made by Nokia (NYSE: NOK). We watched it go by way of so many others in the wake of the iPhone made by Apple (NASDAQ:APPL) and devices powered by Android from Google (NASDAQ: GOOG). (Google is now Alphabet and its ticker is GOOGL) Well, you may Continue reading →

Posted by TwillyD May 17, 2016

Regenerative Medicine Company Faces NASDAQ Delisting

After being given roughly a month to show that it had gotten its financials in order, Osiris Therapeutics (NASDAQ: OSIR) has failed and faces a real chance of being delisted. On Monday, the company provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ. In March, Osiris received a Continue reading →

The DOL Fiduciary Rule is Here; Now What for Advisors and Insurers

If you invest in variable or fixed annuities, you will see some changes in the commission costs soon. That’s due to the Department of Labor’s new fiduciary rule that will begin taking effect over the coming months. The investment advisors who sell the products and the insurance companies that employ them are all on alert Continue reading →

Oracle Making Strong Entry Into Cloud; Is It Too Late to Grab Market Share

“What the Hell is Cloud Computing?” That was the question posed by Oracle founder Larry Ellison about eight years ago when he spoke to a gathering of financial analysts. Since then, it seems Ellison, now chief technology officer, of Oracle (NASDAQ: ORCL) has been enlightened. That, or Ellison has adopted the policy of, “if you Continue reading →

Herbalife, Still Trying to Shake Bill Ackman, Could Beat on Q1 Earnings

The much put upon Herbalife (NYSE: HLF) will post its earnings for the first quarter of fiscal 2016 on Thursday, and I’m going to go out on a limb and anticipate it will meet analysts’ estimates, if not beat them. When I say “much put upon,” and “going out on a limb,” I’m referring to Continue reading →

Don’t Count These Apple Suppliers Out Based on Slowed iPhone Sales

The disappointing earnings Apple (NASDAQ: AAPL) posted lastweek caused its stock to tank. We saw investors not only flee their positions in the iPhone maker, but we also saw them fleeing companies that supply the parts that Apple uses to build its smartphones, iPads and other devices. The knee jerk reaction to this decline for Continue reading →

How an Elevator Company More Than 160 Years Old is Using Disruptive Technology to Reach the Cloud

When you think about elevators, you may become instantly bored. Up, down… what else is to it? Well, Otis Elevators, a unit of United Technologies (NYSE: UTX), is recognizing that there is a lot more to it when you tap into the disruptive technology known as the Internet of Things, or IoT. Over the last Continue reading →

Whatever Their Q1 2016 Earnigns, Biotech/Biopharma Companies Are Strong Long-Term Plays

We’re into our third week of Q1 2016 earnings reports, and we have seen sectors we thought would horribly disappoint, beat estimates, while those that many thought would beat with flying colors, disappointed. Up this week to report their most recent earnings are several biotech and biopharma companies. Despite the volatility in the spaces, I Continue reading →